Insider Transaction Report

Holger Weis, Chief Executive Officer of Alaunos Therapeutics, Inc. (TCRT), acquired 3,880 shares of common stock on June 30, 2026. The shares were issued in lieu of net salary at a price of $2.26 per share. Following this transaction, Weis now owns 16,552 shares of common stock directly. This report is filed on Form 4.